BioScrip receives URAC accreditation
ELMSFORD, N.Y. — Washington-based healthcare accrediting organization URAC has awarded specialty pharmacy and mail-service pharmacy accreditation to BioScrip, the specialty pharmacy provider said Wednesday.
“BioScrip is very pleased to have been awarded full accreditation for both specialty pharmacy and mail-serve pharmacy from URAC,” BioScrip president and CEO Richard Smith said. “Going through the process challenged us to find better ways to serve our customers, and it is a constant reminder that our first responsibility is to the patient and the quality of clinical serve we provide.”
The accreditation required BioScrip to participate in a complex application process that included comprehensive review of its customer service and clinical pharmacy processes against a combined 146 quality standards by expert analysts, the company said.
Shire files lawsuit against Watson over Adderall XR
DUBLIN — British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.
Shire announced Wednesday that it had filed the suit in the U.S. District Court for the Southern District of New York against Watson and several subsidiaries over their attempt to market a generic version of Adderall XR (amphetamine, dextroamphetamine mixed salts) and breach of contract.
The suit alleges that Watson infringed on three Shire patents and breached a settlement and licensing agreement concerning the drug that the companies reached in November 2007 by filing for approval of a generic version of Adderall XR with the Food and Drug Administration.
Senate repeals 1099 tax reporting requirement
WASHINGTON — The U.S. Senate Tuesday voted to repeal a law that posed a burdensome tax reporting requirement for businesses.
In an 87-12 decision, the legislative body passed H.R. 4, the Small Business Paperwork Mandate Elimination Act, sponsored by Rep. Dan Lungren, R-Calif. The bill repeals a provision in the Patient Protection and Affordable Care Act of 2010 that required businesses to file a Form 1099 with the Internal Revenue Service whenever they made noncredit-card payments totaling $600 or more to a vendor during a single year.
The news follows one month after the House of Representatives voted 314-112 to approve the bill.
In response to the bill’s passing, the National Community Pharmacists Association commended the House and Senate for their efforts. “This bill will allow local pharmacists to spend more time providing expert medication counseling and care to patients and less time filling out paperwork for the IRS," NCPA said. "That’s why NCPA has long been an active member of the Small Business Coalition for Affordable Healthcare, which has been vocal from the start in seeking legislative solutions to this potential problem."
In addition to the NCPA, the National Association of Chain Drug Stores also lauded the decision, noting that it has consistently supported bicameral and bipartisan efforts to repeal the 1099 requirement.
“Repealing the burdensome 1099 provision is in the best interest of economic growth and job creation, and permits pharmacies — the face of neighborhood health care — to provide the most accessible and affordable healthcare services to patients," said NACDS president and CEO Steve Anderson. "Everyone is better served when pharmacy can focus on patients, not paperwork."